Annual Revenue
$170.28 M
-$15.03 M-8.11%
December 31, 2023
Summary
- As of February 7, 2025, ADPT annual revenue is $170.28 million, with the most recent change of -$15.03 million (-8.11%) on December 31, 2023.
- During the last 3 years, ADPT annual revenue has risen by +$71.89 million (+73.08%).
- ADPT annual revenue is now -8.11% below its all-time high of $185.31 million, reached on December 31, 2022.
Performance
ADPT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$46.44 M
+$3.25 M+7.51%
September 30, 2024
Summary
- As of February 7, 2025, ADPT quarterly revenue is $46.44 million, with the most recent change of +$3.25 million (+7.51%) on September 30, 2024.
- Over the past year, ADPT quarterly revenue has increased by +$651.00 thousand (+1.42%).
- ADPT quarterly revenue is now -15.88% below its all-time high of $55.20 million, reached on December 31, 2022.
Performance
ADPT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$177.28 M
+$8.52 M+5.05%
September 30, 2024
Summary
- As of February 7, 2025, ADPT TTM revenue is $177.28 million, with the most recent change of +$8.52 million (+5.05%) on September 30, 2024.
- Over the past year, ADPT TTM revenue has increased by +$7.01 million (+4.11%).
- ADPT TTM revenue is now -6.50% below its all-time high of $189.60 million, reached on June 30, 2023.
Performance
ADPT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ADPT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.1% | +1.4% | +4.1% |
| 3 y3 years | +73.1% | +6.4% | +11.0% |
| 5 y5 years | +205.9% | +6.4% | +11.0% |
ADPT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.1% | +10.3% | -15.9% | +23.3% | -6.5% | +14.9% |
| 5 y | 5-year | -8.1% | +100.2% | -15.9% | +122.1% | -6.5% | +108.4% |
| alltime | all time | -8.1% | +342.9% | -15.9% | +378.0% | -6.5% | +1724.8% |
Adaptive Biotechnologies Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $46.44 M(+7.5%) | $177.28 M(+5.0%) |
| Jun 2024 | - | $43.19 M(+3.1%) | $168.77 M(-3.3%) |
| Mar 2024 | - | $41.87 M(-8.5%) | $174.50 M(+2.5%) |
| Dec 2023 | $170.28 M(-8.1%) | $45.78 M(+20.7%) | $170.28 M(-5.2%) |
| Sep 2023 | - | $37.92 M(-22.5%) | $179.69 M(-5.2%) |
| Jun 2023 | - | $48.93 M(+30.0%) | $189.60 M(+2.9%) |
| Mar 2023 | - | $37.65 M(-31.8%) | $184.34 M(-0.5%) |
| Dec 2022 | $185.31 M(+20.1%) | $55.20 M(+15.4%) | $185.31 M(+10.3%) |
| Sep 2022 | - | $47.83 M(+9.6%) | $168.04 M(+5.2%) |
| Jun 2022 | - | $43.66 M(+13.1%) | $159.68 M(+3.3%) |
| Mar 2022 | - | $38.62 M(+1.8%) | $154.52 M(+0.1%) |
| Dec 2021 | $154.34 M | $37.93 M(-3.9%) | $154.34 M(+5.3%) |
| Sep 2021 | - | $39.47 M(+2.5%) | $146.60 M(+9.9%) |
| Jun 2021 | - | $38.51 M(+0.2%) | $133.43 M(+15.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $38.44 M(+27.4%) | $115.91 M(+17.8%) |
| Dec 2020 | $98.38 M(+15.6%) | $30.18 M(+14.8%) | $98.38 M(+6.5%) |
| Sep 2020 | - | $26.30 M(+25.3%) | $92.41 M(+0.3%) |
| Jun 2020 | - | $20.99 M(+0.4%) | $92.17 M(-1.2%) |
| Mar 2020 | - | $20.91 M(-13.6%) | $93.31 M(+9.7%) |
| Dec 2019 | $85.07 M(+52.8%) | $24.21 M(-7.1%) | $85.07 M(+9.0%) |
| Sep 2019 | - | $26.06 M(+17.7%) | $78.05 M(+12.8%) |
| Jun 2019 | - | $22.14 M(+74.8%) | $69.18 M(+18.0%) |
| Mar 2019 | - | $12.67 M(-26.3%) | $58.61 M(+5.3%) |
| Dec 2018 | $55.66 M(+44.8%) | $17.19 M(+0.0%) | $55.66 M(+44.7%) |
| Sep 2018 | - | $17.19 M(+48.6%) | $38.47 M(+80.8%) |
| Jun 2018 | - | $11.57 M(+19.1%) | $21.28 M(+119.1%) |
| Mar 2018 | - | $9.71 M | $9.71 M |
| Dec 2017 | $38.45 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual revenue?
- What is the all time high annual revenue for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual revenue year-on-year change?
- What is Adaptive Biotechnologies quarterly revenue?
- What is the all time high quarterly revenue for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly revenue year-on-year change?
- What is Adaptive Biotechnologies TTM revenue?
- What is the all time high TTM revenue for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM revenue year-on-year change?
What is Adaptive Biotechnologies annual revenue?
The current annual revenue of ADPT is $170.28 M
What is the all time high annual revenue for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual revenue is $185.31 M
What is Adaptive Biotechnologies annual revenue year-on-year change?
Over the past year, ADPT annual revenue has changed by -$15.03 M (-8.11%)
What is Adaptive Biotechnologies quarterly revenue?
The current quarterly revenue of ADPT is $46.44 M
What is the all time high quarterly revenue for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly revenue is $55.20 M
What is Adaptive Biotechnologies quarterly revenue year-on-year change?
Over the past year, ADPT quarterly revenue has changed by +$651.00 K (+1.42%)
What is Adaptive Biotechnologies TTM revenue?
The current TTM revenue of ADPT is $177.28 M
What is the all time high TTM revenue for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM revenue is $189.60 M
What is Adaptive Biotechnologies TTM revenue year-on-year change?
Over the past year, ADPT TTM revenue has changed by +$7.01 M (+4.11%)